Paper39596227
Monitoring and Treatment of Paroxysmal Nocturnal Hemoglobinuria in Patients with Aplastic Anemia in Asia: An Expert Consensus.
Wong RSM and 10 others. Int J Mol Sci, 2024. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Monitoring and Treatment of Paroxysmal Nocturnal Hemoglobinuria in Patients with Aplastic Anemia in Asia: An Expert Consensus. Papers, record 39596227. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39596227
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Monitoring and Treatment of Paroxysmal Nocturnal Hemoglobinuria in Patients with Aplastic Anemia in Asia: An Expert Consensus.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hemoglobinuria, Paroxysmal | Major topic |
| Anemia, Aplastic | Major topic |
| Humans | |
| Asia | |
| L-Lactate Dehydrogenase | |
| Flow Cytometry | |
| Reticulocyte Count |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| NA | AstraZeneca Rare Disease | PubMed | ||
| NA | Alexion | PubMed |
Source PubMed
References74
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30354958 | Aplastic Anemia. | N Engl J Med | 2018 | https://conductscience.org/library/papers/30354958 | PubMed |
| 2 | 34057336 | Hematopoietic Stem Cell Transplantation for Patients with Paroxysmal Nocturnal Hemoglobinuria with or without Aplastic Anemia: A Multicenter Turkish Experience | Turk J Haematol | 2021 | https://conductscience.org/library/papers/34057336 | PubMed |
| 3 | 25237200 | Paroxysmal nocturnal hemoglobinuria. | Blood | 2014 | https://conductscience.org/library/papers/25237200 | PubMed |
| 4 | 29075054 | Diagnosis of Paroxysmal Nocturnal Hemoglobinuria: Recent Advances. | Indian J Hematol Blood Transfus | 2017 | https://conductscience.org/library/papers/29075054 | PubMed |
| 5 | 22689687 | Allogeneic stem cell transplantation in paroxysmal nocturnal hemoglobinuria. | Haematologica | 2012 | https://conductscience.org/library/papers/22689687 | PubMed |
| 6 | 16051736 | Diagnosis and management of paroxysmal nocturnal hemoglobinuria. | Blood | 2005 | https://conductscience.org/library/papers/16051736 | PubMed |
| 7 | 32869125 | Results from multinational phase 3 studies of ravulizumab (ALXN1210) versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria: subgroup analysis of Japanese patients. | Int J Hematol | 2020 | https://conductscience.org/library/papers/32869125 | PubMed |
| 8 | 30242915 | How we treat paroxysmal nocturnal hemoglobinuria: A consensus statement of the Canadian PNH Network and review of the national registry. | Eur J Haematol | 2019 | https://conductscience.org/library/papers/30242915 | PubMed |
| 9 | 32195308 | Laboratory studies for paroxysmal nocturnal hemoglobinuria, with emphasis on flow cytometry. | Pract Lab Med | 2020 | https://conductscience.org/library/papers/32195308 | PubMed |
| 10 | 29236352 | ICCS/ESCCA consensus guidelines to detect GPI-deficient cells in paroxysmal nocturnal hemoglobinuria (PNH) and related disorders part 1 - clinical utility. | Cytometry B Clin Cytom | 2018 | https://conductscience.org/library/papers/29236352 | PubMed |
| 11 | 34986284 | Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia. | N Engl J Med | 2022 | https://conductscience.org/library/papers/34986284 | PubMed |
| 12 | 32713742 | Consensus statement for diagnosis and treatment of paroxysmal nocturnal haemoglobinuria. | Hematol Transfus Cell Ther | 2021 | https://conductscience.org/library/papers/32713742 | PubMed |
| 13 | 37191286 | Prognostic value of pre-treatment PNH clone among the patients with aplastic anemia: a meta-analysis. | Hematology | 2023 | https://conductscience.org/library/papers/37191286 | PubMed |
| 14 | 27598686 | Diagnostic screening of paroxysmal nocturnal hemoglobinuria: Prospective multicentric evaluation of the current medical indications. | Cytometry B Clin Cytom | 2017 | https://conductscience.org/library/papers/27598686 | PubMed |
| 15 | 29498107 | First line treatment of aplastic anemia with thymoglobuline in Europe and Asia: Outcome of 955 patients treated 2001-2012. | Am J Hematol | 2018 | https://conductscience.org/library/papers/29498107 | PubMed |
| 16 | 36115690 | Clonality in immune aplastic anemia: Mechanisms of immune escape or malignant transformation. | Semin Hematol | 2022 | https://conductscience.org/library/papers/36115690 | PubMed |
| 17 | 29545341 | Concurrent treatment of aplastic anemia/paroxysmal nocturnal hemoglobinuria syndrome with immunosuppressive therapy and eculizumab: a UK experience. | Haematologica | 2018 | https://conductscience.org/library/papers/29545341 | PubMed |
| 18 | 37356012 | Clonal evolution in aplastic anemia: failed tumor surveillance or maladaptive recovery? | Leuk Lymphoma | 2023 | https://conductscience.org/library/papers/37356012 | PubMed |
| 19 | 30171728 | Diagnosis and management of PNH: Review and recommendations from a Belgian expert panel. | Eur J Haematol | 2018 | https://conductscience.org/library/papers/30171728 | PubMed |
| 20 | 30047412 | The Pathophysiology of Acquired Aplastic Anemia: Current Concepts Revisited. | Hematol Oncol Clin North Am | 2018 | https://conductscience.org/library/papers/30047412 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42018243 | Prognostic significance of PNH clones in aplastic anemia treated with immunosuppression or allogeneic HSCT: a 20-year single-center experience. | Blood Res | 2026 | https://conductscience.org/library/papers/42018243 | PubMed |
| 41367019 | A rare case of littoral cell angioma with paroxysmal nocturnal hemoglobinuria. | Medicine (Baltimore) | 2025 | https://conductscience.org/library/papers/41367019 | PubMed |
| 40188230 | Protective factors, management and prognosis of mixed chimerism after allogeneic hematopoietic stem cell transplantation for severe aplastic anemia in children. | Bone Marrow Transplant | 2025 | https://conductscience.org/library/papers/40188230 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39596227
GET https://conductscience.org/api/papers/v1/39596227/references?page=2